{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T07:24:44Z","timestamp":1789197884810,"version":"build-2803163510"},"reference-count":54,"publisher":"Spandidos Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.3892\/ijo.2013.1794","type":"journal-article","created":{"date-parts":[[2013,1,23]],"date-time":"2013-01-23T11:42:43Z","timestamp":1358941363000},"page":"803-809","source":"Crossref","is-referenced-by-count":42,"title":["The RANKL\/RANK system as a therapeutic target for bone invasion by oral squamous cell carcinoma"],"prefix":"10.3892","volume":"42","author":[{"given":"EIJIRO","family":"JIMI","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MASASHI","family":"SHIN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HIROYUKI","family":"FURUTA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YUKIYO","family":"TADA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JINGO","family":"KUSUKAWA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2013,1,23]]},"reference":[{"key":"key20180107180805_b1-ijo-42-03-0803","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1056\/NEJMra0707975","article-title":"Recent advances in head and neck cancer","volume":"359","author":"Haddad","year":"2008","journal-title":"N Engl J Med"},{"key":"key20180107180805_b2-ijo-42-03-0803","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.1200\/JCO.2009.27.0397","article-title":"Epidermal growth factor receptor inhibitor gefitinib added to chemoradiotherapy in locally advanced head and neck cancer","volume":"28","author":"Cohen","year":"2010","journal-title":"J Clin Oncol"},{"key":"key20180107180805_b3-ijo-42-03-0803","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/j.1601-0825.2010.01781.x","article-title":"The cellular and molecular mechanisms of bone invasion by oral squamous cell carcinoma","volume":"17","author":"Jimi","year":"2011","journal-title":"Oral Dis"},{"key":"key20180107180805_b4-ijo-42-03-0803","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1002\/1097-0347(200012)22:8<794::AID-HED8>3.0.CO;2-W","article-title":"Prognostic implications of mandibular invasion in oral cancer","volume":"22","author":"Ash","year":"2000","journal-title":"Head Neck"},{"key":"key20180107180805_b5-ijo-42-03-0803","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/j.1600-0714.1996.tb00292.x","article-title":"Histomorphometric analysis of osteoclastic resorption in bone directly invaded by gingival squamous cell carcinoma","volume":"25","author":"Semba","year":"1996","journal-title":"J Oral Pathol Med"},{"key":"key20180107180805_b6-ijo-42-03-0803","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/hed.2880130107","article-title":"Mandibular involvement by squamous cell carcinoma of the lower alveolus: analysis and comparative study of histologic and radiologic features","volume":"13","author":"Totsuka","year":"1991","journal-title":"Head Neck"},{"key":"key20180107180805_b7-ijo-42-03-0803","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1053\/joms.2000.7252","article-title":"Repair of the inferior alveolar nerve with a forearm cutaneous nerve graft after ablative surgery of the mandible","volume":"58","author":"Shibahara","year":"2000","journal-title":"J Oral Maxillofac Surg"},{"key":"key20180107180805_b8-ijo-42-03-0803","first-page":"686","article-title":"Buccal mucosa, alveolus, retromolar trigone, floor of mouth, hard palate, and tongue tumors","volume-title":"Comprehensive Management of Head and Neck Tumors","author":"Shah","year":"1999","edition":"2nd edition"},{"key":"key20180107180805_b9-ijo-42-03-0803","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/0002-9610(83)90229-5","article-title":"Patterns and mechanisms of bone invasion by squamous carcinomas of the head and neck","volume":"146","author":"Carter","year":"1983","journal-title":"Am J Surg"},{"key":"key20180107180805_b10-ijo-42-03-0803","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S1010-5182(05)80203-3","article-title":"Mandibular invasion by oral squamous cell carcinoma. Clinical aspects","volume":"18","author":"M\u00fcller","year":"1990","journal-title":"J Craniomaxillofac Surg"},{"key":"key20180107180805_b11-ijo-42-03-0803","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/hed.2880130206","article-title":"Results of surgical treatment for squamous carcinoma of the lower alveolus: segmental vs. marginal resection","volume":"13","author":"Totsuka","year":"1991","journal-title":"Head Neck"},{"key":"key20180107180805_b12-ijo-42-03-0803","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/00005537-200001000-00013","article-title":"Histological pattern of mandibular invasion by oral squamous cell carcinoma","volume":"110","author":"Wong","year":"2000","journal-title":"Laryngoscope"},{"key":"key20180107180805_b13-ijo-42-03-0803","first-page":"18","article-title":"Cancer and bone","volume":"19","author":"Guise","year":"1998","journal-title":"Endocr Rev"},{"key":"key20180107180805_b14-ijo-42-03-0803","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.ijom.2005.03.008","article-title":"A study of osteoclast-related cytokines in mandibular invasion by squamous cell carcinoma","volume":"34","author":"Shibahara","year":"2005","journal-title":"Int J Oral Maxillofac Surg"},{"key":"key20180107180805_b15-ijo-42-03-0803","doi-asserted-by":"crossref","first-page":"3597","DOI":"10.1073\/pnas.95.7.3597","article-title":"Osteoclast differentiation factor is a ligand for osteoprotegerin\/osteoclastogenesis-inhibitory factor and is identical to TRANCE\/RANKL","volume":"95","author":"Yasuda","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180107180805_b16-ijo-42-03-0803","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0092-8674(00)81569-X","article-title":"Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation","volume":"93","author":"Lacey","year":"1998","journal-title":"Cell"},{"key":"key20180107180805_b17-ijo-42-03-0803","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1006\/bbrc.1997.6603","article-title":"Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis","volume":"234","author":"Tsuda","year":"1997","journal-title":"Biochem Biophys Res Commun"},{"key":"key20180107180805_b18-ijo-42-03-0803","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0092-8674(00)80209-3","article-title":"Osteoprotegerin: a novel secreted protein involved in the regulation of bone density","volume":"89","author":"Simonet","year":"1997","journal-title":"Cell"},{"key":"key20180107180805_b19-ijo-42-03-0803","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1210\/edrv.20.3.0367","article-title":"Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families","volume":"20","author":"Suda","year":"1999","journal-title":"Endocr Rev"},{"key":"key20180107180805_b20-ijo-42-03-0803","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0736-0266(02)00095-5","article-title":"Differences in the cytokine profiles associated with prostate cancer cell induced osteoblastic and osteolytic lesions in bone","volume":"21","author":"Lee","year":"2003","journal-title":"J Orthop Res"},{"key":"key20180107180805_b21-ijo-42-03-0803","doi-asserted-by":"crossref","first-page":"266","DOI":"10.4049\/jimmunol.179.1.266","article-title":"Receptor activator of NF-\u03baB ligand inhibition suppresses bone resorption and hypercalcemia but does not affect host immune responses to influenza infection","volume":"179","author":"Miller","year":"2007","journal-title":"J Immunol"},{"key":"key20180107180805_b22-ijo-42-03-0803","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/pros.20678","article-title":"RANKL acts directly on RANK-expressing prostate tumor cells and mediates migration and expression of tumor metastasis genes","volume":"68","author":"Armstrong","year":"2008","journal-title":"Prostate"},{"key":"key20180107180805_b23-ijo-42-03-0803","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s10585-007-9127-1","article-title":"Inhibition of RANKL blocks skeletal tumor progression and improves survival in a mouse model of breast cancer bone metastasis","volume":"25","author":"Canon","year":"2008","journal-title":"Clin Exp Metastasis"},{"key":"key20180107180805_b24-ijo-42-03-0803","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.molmed.2005.11.007","article-title":"RANKL-RANK signaling in osteoclastogenesis and bone disease","volume":"12","author":"Wada","year":"2006","journal-title":"Trends Mol Med"},{"key":"key20180107180805_b25-ijo-42-03-0803","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature01658","article-title":"Osteoclast differentiation and activation","volume":"423","author":"Boyle","year":"2003","journal-title":"Nature"},{"key":"key20180107180805_b26-ijo-42-03-0803","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1006\/bbrc.1998.8697","article-title":"Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor\/osteoprotegerin","volume":"247","author":"Mizuno","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"key20180107180805_b27-ijo-42-03-0803","doi-asserted-by":"crossref","first-page":"25190","DOI":"10.1074\/jbc.272.40.25190","article-title":"TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells","volume":"272","author":"Wong","year":"1997","journal-title":"J Biol Chem"},{"key":"key20180107180805_b28-ijo-42-03-0803","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/16852","article-title":"OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis","volume":"397","author":"Kong","year":"1999","journal-title":"Nature"},{"key":"key20180107180805_b29-ijo-42-03-0803","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/36593","article-title":"A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function","volume":"390","author":"Anderson","year":"1997","journal-title":"Nature"},{"key":"key20180107180805_b30-ijo-42-03-0803","doi-asserted-by":"crossref","first-page":"434","DOI":"10.4049\/jimmunol.163.1.434","article-title":"Osteoclast differentiation factor acts as a multifunctional regulator in murine osteoclast differentiation and function","volume":"163","author":"Jimi","year":"1999","journal-title":"J Immunol"},{"key":"key20180107180805_b31-ijo-42-03-0803","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1101\/gad.13.18.2412","article-title":"RANK is essential for osteoclast and lymph node development","volume":"13","author":"Dougall","year":"1999","journal-title":"Genes Dev"},{"key":"key20180107180805_b32-ijo-42-03-0803","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1158\/1078-0432.CCR-05-1933","article-title":"A study of the biological receptor activator of nuclear factor-\u03baB ligand inhibitor, denosumab, in patients with multiple myeloma or bone metastases from breast cancer","volume":"12","author":"Body","year":"2006","journal-title":"Clin Cancer Res"},{"key":"key20180107180805_b33-ijo-42-03-0803","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1097\/01.blo.0000093844.72468.f4","article-title":"Breast cancer metastasis to bone: it is not all about PTHrP","volume":"415","author":"Bendre","year":"2003","journal-title":"Clin Orthop Relat Res"},{"key":"key20180107180805_b34-ijo-42-03-0803","doi-asserted-by":"crossref","first-page":"4451","DOI":"10.1210\/endo.140.10.7037","article-title":"Breast cancer cells interact with osteoblasts to support osteoclast formation","volume":"140","author":"Thomas","year":"1999","journal-title":"Endocrinology"},{"key":"key20180107180805_b35-ijo-42-03-0803","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S0090-4295(00)01122-5","article-title":"Osteoprotegerin and RANK ligand expression in prostate cancer","volume":"57","author":"Brown","year":"2001","journal-title":"Urology"},{"key":"key20180107180805_b36-ijo-42-03-0803","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1182\/blood-2002-09-2684","article-title":"RANK ligand and osteoprotegerin in myeloma bone disease","volume":"101","author":"Sezer","year":"2003","journal-title":"Blood"},{"key":"key20180107180805_b37-ijo-42-03-0803","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1158\/0008-5472.CAN-03-1131","article-title":"Cancer and the microenvironment: myeloma-osteoclast interactions as a model","volume":"64","author":"Yaccoby","year":"2004","journal-title":"Cancer Res"},{"key":"key20180107180805_b38-ijo-42-03-0803","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1006\/bbrc.2000.2314","article-title":"Cancer cells responsible for humoral hypercalcemia express mRNA encoding a secreted form of ODF\/TRANCE that induces osteoclast formation","volume":"269","author":"Nagai","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"key20180107180805_b39-ijo-42-03-0803","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/ijc.21008","article-title":"Oral squamous cell carcinoma cells induce osteoclast differentiation by suppression of osteoprotegerin expression in osteoblasts","volume":"116","author":"Tada","year":"2005","journal-title":"Int J Cancer"},{"key":"key20180107180805_b40-ijo-42-03-0803","doi-asserted-by":"crossref","first-page":"968","DOI":"10.2353\/ajpath.2010.090299","article-title":"Roles of interleukin-6 and parathyroid hormone-related peptide in osteoclast formation associated with oral cancers: significance of interleukin-6 synthesized by stromal cells in response to cancer cells","volume":"176","author":"Kayamori","year":"2010","journal-title":"Am J Pathol"},{"key":"key20180107180805_b41-ijo-42-03-0803","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/j.1600-0714.2009.00793.x","article-title":"Immunohistochemical expression of RANKL, RANK, and OPG in human oral squamous cell carcinoma","volume":"38","author":"Chuang","year":"2009","journal-title":"J Oral Pathol Med"},{"key":"key20180107180805_b42-ijo-42-03-0803","first-page":"5438","article-title":"Receptor activator of nuclear factor-\u03baB ligand expression by human myeloma cells mediates osteoclast formation in vitro and correlates with bone destruction in vivo","volume":"63","author":"Farrugia","year":"2003","journal-title":"Cancer Res"},{"key":"key20180107180805_b43-ijo-42-03-0803","doi-asserted-by":"crossref","first-page":"3527","DOI":"10.1182\/blood.V98.13.3527","article-title":"Myeloma cells induce imbalance in the osteoprotegerin\/osteoprotegerin ligand system in the human bone marrow environment","volume":"98","author":"Giuliani","year":"2001","journal-title":"Blood"},{"key":"key20180107180805_b44-ijo-42-03-0803","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0006-291X(02)02937-6","article-title":"Role of prostaglandin E produced by osteoblasts in osteolysis due to bone metastasis","volume":"300","author":"Ohshiba","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"key20180107180805_b45-ijo-42-03-0803","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.canlet.2008.09.015","article-title":"Oral squamous cell carcinoma cells modulate osteoclast function by RANKL-dependent and -independent mechanisms","volume":"274","author":"Tada","year":"2009","journal-title":"Cancer Lett"},{"key":"key20180107180805_b46-ijo-42-03-0803","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1006\/excr.1998.4320","article-title":"Interleukin 1 induces multinucleation and bone-resorbing activity of osteoclasts in the absence of osteoblasts\/stromal cells","volume":"247","author":"Jimi","year":"1999","journal-title":"Exp Cell Res"},{"key":"key20180107180805_b47-ijo-42-03-0803","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/nature04524","article-title":"Regulation of cancer cell migration and bone metastasis by RANKL","volume":"440","author":"Jones","year":"2006","journal-title":"Nature"},{"key":"key20180107180805_b48-ijo-42-03-0803","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1093\/carcin\/bgr198","article-title":"The inhibition of RANKL\/RANK signaling by osteoprotegerin suppresses bone invasion by oral squamous cell carcinoma cells","volume":"32","author":"Shin","year":"2011","journal-title":"Carcinogenesis"},{"key":"key20180107180805_b49-ijo-42-03-0803","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1002\/cncr.11138","article-title":"A phase I study of AMGN-0007, a recombinant osteoprotegerin construct, in patients with multiple myeloma or breast carcinoma related bone metastases","volume":"97","author":"Body","year":"2003","journal-title":"Cancer"},{"key":"key20180107180805_b50-ijo-42-03-0803","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1359\/jbmr.2001.16.2.348","article-title":"The effect of a single dose of osteoprotegerin in postmenopausal women","volume":"16","author":"Bekker","year":"2001","journal-title":"J Bone Miner Res"},{"key":"key20180107180805_b51-ijo-42-03-0803","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ctrv.2007.09.002","article-title":"RANK ligand as a therapeutic target for bone metastases and multiple myeloma","volume":"34","author":"Roodman","year":"2008","journal-title":"Cancer Treatment Rev"},{"key":"key20180107180805_b52-ijo-42-03-0803","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1177\/1758834011412656","article-title":"Denosumab for the treatment of bone metastases in breast cancer: evidence and opinion","volume":"3","author":"Steger","year":"2011","journal-title":"Ther Adv Med Oncol"},{"key":"key20180107180805_b53-ijo-42-03-0803","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s00198-010-1177-6","article-title":"Denosumab-related osteonecrosis of the jaws","volume":"22","author":"Kyrgidis","year":"2011","journal-title":"Osteoporos Int"},{"key":"key20180107180805_b54-ijo-42-03-0803","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1177\/154405910808700104","article-title":"Molecular pathogenesis of oral squamous cell carcinoma: implications for therapy","volume":"87","author":"Choi","year":"2008","journal-title":"J Dent Res"}],"container-title":["International Journal of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ijo.2013.1794\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T22:20:35Z","timestamp":1687990835000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ijo.2013.1794"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,23]]},"references-count":54,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2013,1,23]]},"published-print":{"date-parts":[[2013,3]]}},"alternative-id":["10.3892\/ijo.2013.1794"],"URL":"https:\/\/doi.org\/10.3892\/ijo.2013.1794","relation":{},"ISSN":["1019-6439","1791-2423"],"issn-type":[{"value":"1019-6439","type":"print"},{"value":"1791-2423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,23]]}}}